• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Bristol-Myers Squibb, LabCentral partner for startups in Massachusetts

Bristol-Myers Squibb, LabCentral partner for startups in Massachusetts

March 8, 2016
CenterWatch Staff

Bristol-Myers Squibb and LabCentral, an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups, have announced an agreement in which Bristol-Myers Squibb has become a LabCentral platinum sponsor. Bristol-Myers Squibb can nominate up to two innovative life sciences and biotech startup companies per year to take up residence in LabCentral’s Kendall Square facilities. The 2016 nomination process for Bristol-Myers Squibb-sponsored Golden Tickets will launch by the end of the first quarter.

“We are thrilled to welcome Bristol-Myers Squibb to Kendall Square and excited to have it join LabCentral’s growing roster of global-company sponsors,” said LabCentral Co-Founder and President, Johannes Fruehauf, M.D., Ph.D. “Clearly, the LabCentral model—providing functional units of space and creating a supportive environment for nascent companies—is meeting a resounding need in the marketplace. Our residents who are working to move early-stage science from the lab bench toward clinical trials stand to gain valuable insights from regular interactions with Bristol-Myers Squibb mentors who are veterans of the process. But we believe it’s a symbiotic relationship; this partnership will enable Bristol-Myers Squibb to benefit from proximity and better access to our entrepreneurs as well as LabCentral alumni and others working in some of the region’s most exciting life-sciences startups.”

“Bristol-Myers Squibb is excited to partner with LabCentral, which serves as a launch pad for scientific innovation, as it naturally aligns with our focus on accelerating the discovery and development of potentially transformational medicines for patients with serious diseases,” said Carl Decicco, Ph. D., head of Discovery at Bristol-Myers Squibb. “This sponsorship also builds on our growing commitment to the Cambridge community, one of the most vibrant ecosystems of world class science, innovation and entrepreneurship.”

In June 2015, Bristol-Myers Squibb announced  it would open a new state-of the-art research site in Cambridge, Massachusetts. The new facility will be located at 100 Binney Street in Kendall Square and is expected to open in early 2018.

Regarding Golden Tickets, Dr. Fruehauf said, “Collaboration is also a fundamental tenet underlying the LabCentral Golden Ticket program. A Golden Ticket represents one underwritten bench space per year for one scientist at LabCentral and a priority spot on the waiting list—invaluable for an early-stage company with limited resources. However, equally important is the close bonds that are formed between fledgling start-up and sponsor; the program provides sponsors with important early access to potentially transformational targets and technology. Anecdotally, I also hear that the enthusiasm of our entrepreneurs and the cross-fertilization of science and ideas that takes place at LabCentral energizes sponsors to bring some of that ‘start-up spirit’ back to their regular workplace.” Dr. Fruehauf added, “We look forward to a fruitful, long-term alliance with Bristol-Myers Squibb.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing